Hepatitis Monthly

Published by: Kowsar

Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma

Jia Wen Yin 1 , ** , Mao Ping Huang 2 and Bei Zhong 2 , **
Authors Information
1 The State Key Laboratory of Bioelectronics, Southeast University, Nanjing, China
2 The Affiliated Qingyuan People Hospital, Jinan University Medical School, Qingyuan, Guangdong, China
Corresponding Authors:
Article information
  • Hepatitis Monthly: June 2016, 16 (6); e34432
  • Published Online: May 23, 2016
  • Article Type: Research Article
  • Received: November 7, 2015
  • Revised: April 28, 2016
  • Accepted: May 1, 2016
  • DOI: 10.5812/hepatmon.34432

To Cite: Yin J W, Ping Huang M, Zhong B. Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma, Hepat Mon. 2016 ;16(6):e34432. doi: 10.5812/hepatmon.34432.

Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008; 2(3): 263-83[DOI][PubMed]
  • 2. European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56(4): 908-43[DOI][PubMed]
  • 3. Zhong B, Huang MP, Yin GQ, Gao X. Effects of costimulation on intrahepatic immunopathogenesis in patients with chronic HBV infection. Inflamm Res. 2014; 63(3): 217-29[DOI][PubMed]
  • 4. Zhang E, Lu M. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Med Microbiol Immunol. 2015; 204(1): 11-20[DOI][PubMed]
  • 5. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124(4): 783-801[DOI][PubMed]
  • 6. Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A, et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology. 2007; 46(6): 1769-78[DOI][PubMed]
  • 7. Ma Z, Zhang E, Yang D, Lu M. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. Cell Mol Immunol. 2015; 12(3): 273-82[DOI][PubMed]
  • 8. Momeni M, Zainodini N, Bidaki R, Hassanshahi G, Daneshvar H, Khaleghinia M, et al. Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients. Hum Immunol. 2014; 75(1): 15-9[DOI][PubMed]
  • 9. Jiang M, Broering R, Trippler M, Poggenpohl L, Fiedler M, Gerken G, et al. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen. J Viral Hepat. 2014; 21(12): 860-72[DOI][PubMed]
  • 10. Ayoobi F, Hassanshahi G, Zainodini N, Khorramdelazad H, Arababadi MK, Kennedy D. Reduced expression of TRIF in chronic HBV infected Iranian patients. Clin Res Hepatol Gastroenterol. 2013; 37(5): 491-5[DOI][PubMed]
  • 11. Huang YW, Lin SC, Wei SC, Hu JT, Chang HY, Huang SH, et al. Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antivir Ther. 2013; 18(7): 877-84[DOI][PubMed]
  • 12. Wang K, Liu H, He Y, Chen T, Yang Y, Niu Y, et al. Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure. Hum Immunol. 2010; 71(10): 950-6[DOI][PubMed]
  • 13. Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R, et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology. 2009; 49(4): 1132-40[DOI][PubMed]
  • 14. Xia S, Guo Z, Xu X, Yi H, Wang Q, Cao X. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood. 2008; 112(8): 3175-85[DOI][PubMed]
  • 15. Loirat D, Mancini-Bourgine M, Abastado JP, Michel ML. HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection. Int Immunol. 2003; 15(10): 1125-36[PubMed]
  • 16. Maier H, Isogawa M, Freeman GJ, Chisari FV. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol. 2007; 178(5): 2714-20[PubMed]
  • 17. Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, Janssen HL, et al. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol. 2008; 129(3): 419-27[DOI][PubMed]
  • 18. Lok AS, McMahon BJ, Practice Guidelines Committee AAFTSOLD. Chronic hepatitis B. Hepatology. 2001; 34(6): 1225-41[DOI][PubMed]
  • 19. Zhong B, Ma HY, Yang Q, Gu FR, Yin GQ, Xia CM. Decrease in toll-like receptors 2 and 4 in the spleen of mouse with endotoxic tolerance. Inflamm Res. 2008; 57(6): 252-9[DOI][PubMed]
  • 20. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 2000; 31(1): 241-6[DOI][PubMed]
  • 21. Zhan Z, Cao H, Xie X, Yang L, Zhang P, Chen Y, et al. Phosphatase PP4 Negatively Regulates Type I IFN Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating TBK1. J Immunol. 2015; 195(8): 3849-57[DOI][PubMed]
  • 22. Tan Z, Xie N, Banerjee S, Cui H, Fu M, Thannickal VJ, et al. The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages. J Biol Chem. 2015; 290(1): 46-55[DOI][PubMed]
  • 23. Imaizumi T, Numata A, Yano C, Yoshida H, Meng P, Hayakari R, et al. ISG54 and ISG56 are induced by TLR3 signaling in U373MG human astrocytoma cells: possible involvement in CXCL10 expression. Neurosci Res. 2014; 84: 34-42[DOI][PubMed]
  • 24. Erdinest N, Aviel G, Moallem E, Anteby I, Yahalom C, Mechoulam H, et al. Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblasts. J Inflamm (Lond). 2014; 11(1): 3[DOI][PubMed]
  • 25. Li N, Li Q, Qian Z, Zhang Y, Chen M, Shi G. Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage. Biochem Biophys Res Commun. 2009; 390(3): 630-5[DOI][PubMed]
  • 26. Kunitani H, Shimizu Y, Murata H, Higuchi K, Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol. 2002; 36(6): 734-41[PubMed]
  • 27. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol. 2001; 1(3): 220-8[DOI][PubMed]
  • 28. Chen K, Huang J, Gong W, Zhang L, Yu P, Wang JM. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system. Cell Mol Immunol. 2006; 3(3): 163-9[PubMed]
  • 29. Muhanna N, Doron S, Wald O, Horani A, Eid A, Pappo O, et al. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis. Hepatology. 2008; 48(3): 963-77[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader